Literature DB >> 31220468

Alteration in ventricular pressure stimulates cardiac repair and remodeling.

Kazumasa Unno1, Angelos Oikonomopoulos2, Yusuke Fujikawa3, Yusuke Okuno4, Singo Narita3, Tomohiro Kato3, Ryo Hayashida3, Kazuhisa Kondo3, Rei Shibata3, Toyoaki Murohara3, Yanfei Yang5, Seema Dangwal6, Konstantina-Ioanna Sereti7, Qiu Yiling5, Kory Johnson8, Alokkumar Jha9, David E Sosnovik10, Yang Fann8, Ronglih Liao11.   

Abstract

The mammalian heart undergoes complex structural and functional remodeling to compensate for stresses such as pressure overload. While studies suggest that, at best, the adult mammalian heart is capable of very limited regeneration arising from the proliferation of existing cardiomyocytes, how myocardial stress affects endogenous cardiac regeneration or repair is unknown. To define the relationship between left ventricular afterload and cardiac repair, we induced left ventricle pressure overload in adult mice by constriction of the ascending aorta (AAC). One week following AAC, we normalized ventricular afterload in a subset of animals through removal of the aortic constriction (de-AAC). Subsequent monitoring of cardiomyocyte cell cycle activity via thymidine analog labeling revealed that an acute increase in ventricular afterload induced cardiomyocyte proliferation. Intriguingly, a release in ventricular overload (de-AAC) further increases cardiomyocyte proliferation. Following both AAC and de-AAC, thymidine analog-positive cardiomyocytes exhibited characteristics of newly generated cardiomyocytes, including single diploid nuclei and reduced cell size as compared to age-matched, sham-operated adult mouse myocytes. Notably, those smaller cardiomyocytes frequently resided alongside one another, consistent with local stimulation of cellular proliferation. Collectively, our data demonstrate that adult cardiomyocyte proliferation can be locally stimulated by an acute increase or decrease of ventricular pressure, and this mode of stimulation can be harnessed to promote cardiac repair.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aortic constriction; Cardiac remodeling; Cardiac repair; Cardiomyocyte proliferation; Hypertrophy; LV pressure overload

Mesh:

Substances:

Year:  2019        PMID: 31220468      PMCID: PMC6698254          DOI: 10.1016/j.yjmcc.2019.06.006

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  32 in total

1.  LEFT VENTRICULAR TENSION AND STRESS IN MAN.

Authors:  H SANDLER; H T DODGE
Journal:  Circ Res       Date:  1963-08       Impact factor: 17.367

2.  Myocardial recovery using ventricular assist devices: prevalence, clinical characteristics, and outcomes.

Authors:  Marc A Simon; Robert L Kormos; Srinivas Murali; Pradeep Nair; Michael Heffernan; John Gorcsan; Stephen Winowich; Dennis M McNamara
Journal:  Circulation       Date:  2005-08-30       Impact factor: 29.690

3.  Long-term results in patients with idiopathic dilated cardiomyopathy after weaning from left ventricular assist devices.

Authors:  Michael Dandel; Yuguo Weng; Henryk Siniawski; Evgenij Potapov; Hans B Lehmkuhl; Roland Hetzer
Journal:  Circulation       Date:  2005-08-30       Impact factor: 29.690

4.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

5.  Wall stress and patterns of hypertrophy in the human left ventricle.

Authors:  W Grossman; D Jones; L P McLaurin
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

6.  Mouse cardiac surgery: comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies.

Authors:  Oleg Tarnavski; Julie R McMullen; Martina Schinke; Qing Nie; Sekwon Kong; Seigo Izumo
Journal:  Physiol Genomics       Date:  2004-02-13       Impact factor: 3.107

7.  Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury.

Authors:  Kevin Bersell; Shima Arab; Bernhard Haring; Bernhard Kühn
Journal:  Cell       Date:  2009-07-23       Impact factor: 41.582

8.  Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury.

Authors:  Patrick C H Hsieh; Vincent F M Segers; Michael E Davis; Catherine MacGillivray; Joseph Gannon; Jeffery D Molkentin; Jeffrey Robbins; Richard T Lee
Journal:  Nat Med       Date:  2007-07-29       Impact factor: 53.440

9.  Evidence for cardiomyocyte renewal in humans.

Authors:  Olaf Bergmann; Ratan D Bhardwaj; Samuel Bernard; Sofia Zdunek; Fanie Barnabé-Heider; Stuart Walsh; Joel Zupicich; Kanar Alkass; Bruce A Buchholz; Henrik Druid; Stefan Jovinge; Jonas Frisén
Journal:  Science       Date:  2009-04-03       Impact factor: 47.728

10.  Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair.

Authors:  Bernhard Kühn; Federica del Monte; Roger J Hajjar; Yuh-Shin Chang; Djamel Lebeche; Shima Arab; Mark T Keating
Journal:  Nat Med       Date:  2007-07-15       Impact factor: 53.440

View more
  2 in total

1.  Accelerated Growth, Differentiation, and Ploidy with Reduced Proliferation of Right Ventricular Cardiomyocytes in Children with Congenital Heart Defect Tetralogy of Fallot.

Authors:  Tatyana V Sukhacheva; Roman A Serov; Natalia V Nizyaeva; Artem A Burov; Stanislav V Pavlovich; Yulia L Podurovskaya; Maria V Samsonova; Andrey L Chernyaev; Aleksandr I Shchegolev; Alexei I Kim; Leo A Bockeria; Gennady T Sukhikh
Journal:  Cells       Date:  2022-01-05       Impact factor: 6.600

2.  Angiotensin II blockers improve cardiac coronary flow under hemodynamic pressure overload.

Authors:  Wei-Ting Chang; Sudeshna Fisch; Seema Dangwal; Michael Chen; Susan Cheng; Zhih-Cherng Chen; Ronglih Liao
Journal:  Hypertens Res       Date:  2021-02-10       Impact factor: 3.872

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.